Neurological Biomarkers Market is predicted to grow at a CAGR of 4.6% through 2033

The global neurological biomarkers market is projected to have a high-paced CAGR of 4.6% during the forecast period. The current valuation of the neurological biomarkers market is US$ 8 Billion in 2023. The value of the neurological biomarkers market is anticipated to reach a high of US$ 12.5 Billion by the year 2033. The key features pushing …

Dental Hygiene Devices Market is expected to register 4.8% CAGR through 2028

The Dental Hygiene Devices Market is expected to be worth USD 4.4 billion in 2022 and USD 5.9 billion by 2028, growing at a CAGR of 4.8% during the forecast period (2022 to 2028). Basic dental hygiene devices include toothpastes and toothbrushes. Dental hygiene devices are designed to aid in the maintenance of oral hygiene, …

Bioimpedance Devices Market is expected to reach US$ 715.1 million by 2028

The global Bioimpedance Devices Market is expected to exceed US$ 492.1 Million in 2022. The market is expected to reach US$ 715.1 Million by 2028, growing at a healthy 6.4% CAGR. Increasing CKD disease cases are expected to fuel the growth of the Bioimpedance Devices Market over the forecast period. Chronic kidney disease (CKD) is …

Onychomycosis Treatment Market is expected to secure US$ 10 Billion by 2032

In 2022, the global onychomycosis treatment market is expected to be worth US$ 4.44 billion. From 2022 to 2032, the onychomycosis treatment market is expected to grow at an 8.46% CAGR and reach a value of US$ 10 billion. The market’s expansion can be attributed to the rising prevalence of diabetes, which increases the risk …

Paediatric Spasticity Treatment Market is likely to register a CAGR of 10% from 2022-2032 | FMI

[324 Pages Report] During the forecast period, the paediatric spasticity treatment market is expected to grow at a CAGR of 10%. Rising demand for combination products such as benzodiazepines, imidazole, and gamma-aminobutyric acid analogues is driving the global paediatric spasticity treatment market. Furthermore, demand for paediatric spasticity treatment is increasing as a result of increased awareness and …

Dental Adhesives Market is expected to reach US$ 3.58 Billion by 2032 | FMI

As per the Future Market Insights’ latest industry analysis, the global market valuation for Dental Adhesives Market was around US$ 2.22 Billion in the year 2021, and is expected to reach a CAGR close to 4.5% over the forecast period and estimated to have a market value of US$ 3.58 Billion in 2032. Many facets …

Handheld Dental X-Ray Systems Market in Japan is set to project a 7.6% CAGR by 2032 | FMI

The global Handheld Dental X-Ray Systems Market is expected to be worth US$ 211.9 Million by the end of 2022, and to grow at a CAGR of 6.4% to be worth US$ 397.1 Million by the end of 2032. According to a recent study by Future Market Insights, >150 X-ray shot systems will lead the …

Arthroscopy Visualization Systems Market is expected to reach US$ 902.5 Million by 2032 | FMI

According to Future Market Insights’ latest industry analysis, the market size for the global Arthroscopy Visualization Systems market is expected to reach US$ 453.8 Million in 2022. It is projected to exhibit growth at a CAGR of 7.1% over the forecast period, with an estimated market size of US$ 902.5 Million in 2032. The high demand for arthroscopy visualization systems due to …

Parkinson’s Disease Market is projected to reach value of US$ 17.12 Billion by 2033 | FMI

In fiscal year 2023, the global Parkinson’s Disease Market is expected to be worth US$ 5.41 billion, up from US$ 4.82 billion in fiscal year 2022. The global market is expected to grow at a 12.2% CAGR from 2023 to 2033, reaching a value of US$ 17.12 billion by the end of 2033. According to …

Mucosal Atomization Devices Market is expected to reach US$ 837.7 Million by 2029 | FMI Analyst

According to Future Market Insights (FMI), the global Mucosal Atomization Devices Market was valued at US$ 460.4 Million in 2021 and is predicted to reach US$ 837.7 Million by 2029. The demand growth is majorly driven by the superior efficiency and the painless drug delivery nature of mucosal atomization devices, according to the report. The …